Oxford Covid vaccine: AstraZeneca still waiting for FDA nod to resume US trial
Thursday, 24 September 2020
AstraZeneca is still waiting for the U.S. drug regulator to approve the restart of the clinical trial of its potential COVID-19 vaccine in the United States almost three weeks after it was paused due to safety concerns. The U.S. trial of AstraZeneca's COVID-19 vaccine candidate, initially developed by the University of Oxford, remains on hold...
💡 One News Page Knowledge: Other News Mentions
Global COVID-19 cases rise by a one-day record
Credit: Reuters - Politics Duration: 01:18Published
Russian disinformation aims to sow distrust over coronavirus vaccinesOn Russian state television in September, the Oxford-AstraZeneca coronavirus vaccine was described as a "monkey vaccine" and portrayed as downright dangerous...
Britain's spies defending COVID-19 vaccine work, MI5 chief saysBy Guy Faulconbridge LONDON (Reuters) - British spies are trying to defend COVID-19 vaccine work against hostile powers that seek to either steal or sabotage..
Covid-19: Oxford vaccine phase three results by November-DecemberThe results of phase three trials of the Oxford-AstraZeneca vaccine being conducted in India could be available by “end-November-early December”, raising..
Could AstraZeneca profit from vaccine by July?
Credit: Reuters Studio Duration: 01:12Published
California to review any COVID-19 vaccine
Credit: Reuters - Politics Duration: 01:25Published
Government agency will investigate Trump administration political influence over FDA, CDCBoth agencies have been caught in political crossfire since the start of the pandemic, as preventative health measures became politicized.
Twitter blocks post by top Trump pandemic adviser
Credit: Reuters - Politics Duration: 02:09Published
Gottlieb says "biggest wave" of coronavirus infections still to comeThe former FDA commissioner says the U.S. has "two or three very hard months ahead of us."
Melania Trump stays off campaign trail, citing lingering coughThe first lady has tested negative for COVID-19 since her initial diagnosis.
PM defends funding for Tier 3 regions
Credit: ODN Duration: 02:31Published
Covid: Greater Manchester to move to Tier 3 restrictions from FridayBoris Johnson says he "regrets" a deal over financial support could not be reached with local leaders.
Covid: Oxford University cases triple on previous weekAlmost 70% of positive cases at at the institution are confirmed in the week to 16 October.
UK will get first access to Oxford vaccine, No 10 says
Credit: PA - Press Association STUDIO Duration: 02:20Published
You Might Like
Related videos from verified sources
Related news from verified sources
Tweets about this